Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00748033
Other study ID # YA-CLO-0005
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 2008
Est. completion date August 2008

Study information

Verified date April 2021
Source Wellspect HealthCare
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The primary purpose of this study is to compare the subject's perception (separately for each randomized catheter) of practicing catheterization when using catheters with sodium chloride in wetting solution (using two different activation times) with a standard reference catheter. The hypothesis is that the subjects' perception of catheterization is the same or more positive when using the test catheters compared to the reference catheter.


Description:

The study is designed as a randomized, single-blind, cross-over, single-centre, study in healthy male volunteers. All subjects will first be catheterized with a reference catheter, which is proven to be well tolerated by most subjects. This catheter will be used as a reference catheter to be compared with the randomized catheters. One more reason for this first test is to withdraw subjects who cannot tolerate catheterizations. Subjects will qualify for the randomized part of the study only if the first catheterization could be performed without significant discomfort. When the subject is randomized he will be catheterized with two urinary catheters in a randomized order during one day. The activation times for the wetting solution will be 5 seconds and 24 (± 2h) hours. During each catheterization, the friction at withdrawal will be measured for the catheter using a Tension Test System. The subjects will be blinded. 25 healthy volunteers will be recruited from a single centre in Sweden.


Recruitment information / eligibility

Status Completed
Enrollment 25
Est. completion date August 2008
Est. primary completion date August 2008
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years and older
Eligibility Inclusion Criteria: - Provision of written informed consent - Healthy volunteer - Male aged 18 years or over Exclusion Criteria: - Known or suspected, current impairment of and/or decreased urethral sensibility - History of urethral morbidity - History of urinary tract infection within three months, or ongoing symptomatic urinary tract infection - Use of medications that may affect the urethra´s dryness (anti-cholinergic drugs or cortisone) - Current drug, alcohol or other substance abuse - Other significant disease or condition (e.g. benign prostate hypertrophy, other prostatic lesions), which may interfere with treatment and/or evaluation - Allergy to antibiotics suspected poor compliance with the protocol during the complete study period

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Reference catheter: LoFric PVC, Nelaton 40 cm, CH 12
The subjects were first catheterized with this reference catheter.
LoFric POBE Hydro-Kit II, 5 seconds
An unsalted LoFric POBE Hydro-Kit II, Nelaton 40 cm, CH 12 with sodium chloride in wetting solution, activation time 5 seconds
LoFric POBE Hydro-Kit II, 24 hours
An unsalted LoFric POBE Hydro-Kit II, Nelaton 40 cm, CH 12 with sodium chloride in wetting solution, activation time 24 hours

Locations

Country Name City State
Sweden Karolinska Trial Alliance A2:01, Karolinska University Hospital Stockholm

Sponsors (1)

Lead Sponsor Collaborator
Wellspect HealthCare

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary Subjects' Perception at Insertion of Test Catheter Activated for 5 Seconds, Compared to Reference. The assessment was made in relation to the reference catheter, and the question to the subject was 'How do you experience this procedure/catheterization in comparison with the baseline procedure/catheterization regarding insertion?'. A minimum of two hours elapsed between the catheterizations and each catherization lasted for 3 minutes. The subjects were catheterized three times during one day.
Primary Subjects' Perception at Insertion of Test Catheter Activated for 24 Hours, Compared to Reference. The assessment was made in relation to the reference catheter, and the question to the subject was 'How do you experience this procedure/catheterization in comparison with the baseline procedure/catheterization regarding insertion?'. A minimum of two hours elapsed between the catheterizations and each catherization lasted for 3 minutes. The subjects were catheterized three times during one day.
Primary Subjects' Perception at Withdrawal of Test Catheter Activated for 5 Seconds, Compared to Reference. The assessment was made in relation to the reference catheter, and the question to the subject was 'How do you experience this procedure/catheterization in comparison with the baseline procedure/catheterization regarding withdrawal?'. A minimum of two hours elapsed between the catheterizations and each catherization lasted for 3 minutes. The subjects were catheterized three times during one day.
Primary Subjects' Perception at Withdrawal of Test Catheter Activated for 24 Hours, Compared to Reference. The assessment was made in relation to the reference catheter, and the question to the subject was 'How do you experience this procedure/catheterization in comparison with the baseline procedure/catheterization regarding withdrawal?'. A minimum of two hours elapsed between the catheterizations and each catherization lasted for 3 minutes. The subjects were catheterized three times during one day.
Secondary Comparison of the Perception at Insertion Between 5s and 24h Activation Times. Times Comparison of the perception at insertion between the catheters with 5s and 24h activation times. A minimum of two hours elapsed between the catheterizations and each catherization lasted for 3 minutes. The subjects were catheterized three times during one day.
Secondary Comparison of the Perception at Withdrawal Between 5s and 24h Activation Times. Comparison of the perception at withdrawal between the catheters with 5s and 24h activation times. A minimum of two hours elapsed between the catheterizations and each catherization lasted for 3 minutes. The subjects were catheterized three times during one day.
Secondary Test of Carry-over Effect at Insertion, Mean Rating of Perception on a Scale of 0 to 5 The subjects perception of the catheterization will be classified as very negative, slightly negative, same, slightly positive or very positive.
The mean perception of the 5s and the 24h catheter is calculated for each subject.
The perception was measured on a scale from 1 (=very negative compared to the reference catheter) to 5 (=very positive compared to the reference catheter) and a 3 indicating that the perception was the same for the test catheter as for the reference catheter. Before doing any statistics all answers were reduced by 3 resulting in values from -2 (=very negative compared to the reference catheter) to +2 (=very positive compared to the reference catheter) and a 0 indicating that the perception was the same for the test catheter as for the reference catheter.
A minimum of two hours elapsed between the catheterizations and each catherization lasted for 3 minutes. The subjects were catheterized three times during one day.
Secondary Test of Carry-over Effect at Withdrawal, Mean Rating of Perception on a Scale of 0 to 5 They had five alternative answers.The subjects perception of the catheterization will be classified as very negative, slightly negative, same, slightly positive or very positive.
The mean perception of the 5s and the 24h catheter is calculated for each subject.
The perception was measured on a scale from 1 (=very negative compared to the reference catheter) to 5 (=very positive compared to the reference catheter) and a 3 indicating that the perception was the same for the test catheter as for the reference catheter. Before doing any statistics all answers were reduced by 3 resulting in values from -2 (=very negative compared to the reference catheter) to +2 (=very positive compared to the reference catheter) and a 0 indicating that the perception was the same for the test catheter as for the reference catheter.
A minimum of two hours elapsed between the catheterizations and each catherization lasted for 3 minutes. The subjects were catheterized three times during one day.
Secondary Tension Test System: Ref-24h Mean Tension test system (friction) at withdrawal. Comparison between the reference catheter and the 24 hours activation time. The MEAN for the withdrawal friction was measured in Newton (N). The Tension test system was performed while withdrawing the catheters up to 5 seconds.
Secondary Tension Test System: Ref-24h Work Tension test system (friction) at withdrawal. Comparison between the reference catheter and the 24 hours activation time. The WORK for the withdrawal friction was measured in Joule (J). The Tension test system was performed while withdrawing the catheters up to 5 seconds.
Secondary Tension Test System: Ref-5s MEAN Tension test system (friction) at withdrawal. Comparison between the reference catheter and the 5 seconds activation time. The MEAN for the withdrawal friction was measured in Newton (N). The Tension test system was performed while withdrawing the catheters, up to 5 seconds.
Secondary Tension Test System: Ref-5s WORK Tension test system (friction) at withdrawal. Comparison between the reference catheter and the 5 seconds activation time. The WORK for the withdrawal friction was measured in Joule (J). The Tension test system was performed while withdrawing the catheters, up to 5 seconds.
Secondary Tension Test System: 24h-5s Tension test system (friction) at withdrawal. Comparison between the catheters with 24h activation time and the 5 seconds activation time.
The MEAN for the withdrawal friction was measured in Newton (N).
The Tension test system was performed while withdrawing the catheters, up to 5 seconds.
See also
  Status Clinical Trial Phase
Terminated NCT00804557 - Efficacy And Safety Of The Uro-Ease® Urinary Catheter During Clean Intermittent Catheterization N/A
Active, not recruiting NCT03459963 - Risks and Benefits of Urinary Catheter in Elective Cesarean Section N/A
Suspended NCT06217016 - Effect of ICCAUT Strategy on Postoperative Urinary Retention After Radical Rectal Cancer Surgery (ICCAUT-2) N/A
Recruiting NCT06241703 - Effect of ICCAUT Strategy on Postoperative Urinary Dysfunction After Radical Rectal Cancer Surgery N/A
Not yet recruiting NCT04159077 - REduction of Post-Operative Urinary Retention With Tamsulosin Versus Placebo (REPOURT- P) Trial Phase 3
Completed NCT00753298 - A Randomized, Fully-blinded Parallel Groups Study of Catheter Materials Used for Clean Intermittent Catheterisation N/A
Withdrawn NCT01063452 - Impact of Atkinson Product Design Urinary Slide Valve Versus Standard Catheter Drainage System on Social Functioning Phase 4
Not yet recruiting NCT05710731 - The Urinary Catheterization Training on Skills, Satisfaction and Self-Confidence in Nursing Students N/A